Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sheila A Doggrell

Showing results (71-80 of 220) with videos related to

Pageof 22
Sort By:
Expert Opinion on Pharmacotherapy|December 14, 2007
Is sapropterin treatment suitable for all subjects with phenylketonuria?Sheila A Doggrell
Expert Opinion on Pharmacotherapy|October 27, 2004
Sirolimus- or paclitaxel-eluting stents to prevent coronary artery restenosisSheila A Doggrell
Expert Opinion on Investigational Drugs|June 24, 2004
Intrathecal ziconotide for refractory painSheila A Doggrell
Current Opinion in Investigational Drugs (London, England : 2000)|April 16, 2004
Amediplase. MenariniSheila A Doggrell
Expert Opinion on Pharmacotherapy|August 28, 2004
After ALLHAT: doxazosin for the treatment of benign prostatic hyperplasiaSheila A Doggrell
Drug News & Perspectives|March 3, 2004
Cytokines, signaling and diseases - a pharmacologist's viewSheila A Doggrell
Expert Opinion on Pharmacotherapy|March 12, 2004
Candesartan for the prevention and treatment of stroke - results of the SCOPE and ACCESS trialsSheila A Doggrell,
Expert Opinion on Investigational Drugs|March 12, 2004
Can food intake be reduced with peptide YY3-36?Sheila A Doggrell
Drug News & Perspectives|March 9, 2005
Recent advances in heart researchSheila A Doggrell
Drug News & Perspectives|January 13, 2005
New drugs and new targetsSheila A Doggrell
Pageof 22

Showing results (71-80 of 220) with videos related to

Sort By:
Pageof 22
Expert Opinion on Pharmacotherapy|December 14, 2007
Is sapropterin treatment suitable for all subjects with phenylketonuria?Sheila A Doggrell
Expert Opinion on Pharmacotherapy|October 27, 2004
Sirolimus- or paclitaxel-eluting stents to prevent coronary artery restenosisSheila A Doggrell
Expert Opinion on Investigational Drugs|June 24, 2004
Intrathecal ziconotide for refractory painSheila A Doggrell
Current Opinion in Investigational Drugs (London, England : 2000)|April 16, 2004
Amediplase. MenariniSheila A Doggrell
Expert Opinion on Pharmacotherapy|August 28, 2004
After ALLHAT: doxazosin for the treatment of benign prostatic hyperplasiaSheila A Doggrell
Drug News & Perspectives|March 3, 2004
Cytokines, signaling and diseases - a pharmacologist's viewSheila A Doggrell
Expert Opinion on Pharmacotherapy|March 12, 2004
Candesartan for the prevention and treatment of stroke - results of the SCOPE and ACCESS trialsSheila A Doggrell,
Expert Opinion on Investigational Drugs|March 12, 2004
Can food intake be reduced with peptide YY3-36?Sheila A Doggrell
Drug News & Perspectives|March 9, 2005
Recent advances in heart researchSheila A Doggrell
Drug News & Perspectives|January 13, 2005
New drugs and new targetsSheila A Doggrell
Pageof 22